Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma
Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma
This study is a registry of renal cancer patients treated with Nexavar. It aims to evaluate the actual dosing of Nexavar in "real-life" setting vs. the prescribed dose.
Inclusion Criteria:
Exclusion Criteria:
Many Locations, Poland